Literature DB >> 15340354

Tumor necrosis factor promoter haplotype associated with schizophrenia reveals a linked locus on 1q44.

V Saviouk1, E W C Chow, A S Bassett, L M Brzustowicz.   

Abstract

Using restriction fragment length polymorphism and pyrosequencing methods, we genotyped two TNFA gene promoter SNPs (-G308A, -G238A) and analyzed the haplotype structure in 24 Canadian families of primarily Celtic origin. Our results demonstrate that after correction for multiple testing based on simulations of 10 000 replicates of unlinked/unassociated data, there is evidence for association (P=0.026) of a specific haplotype (-308A, -238G) with schizophrenia and schizophrenia spectrum disorders with a family-based trimmed haplotype linkage disequilibrium test (Trimhap). Stratifying the 22 families with genome scan data by TNFA promoter haplotypes followed by reanalysis of linkage to schizophrenia throughout the genome, we identified few loci that exhibit a considerable increase in LOD/HLOD scores. A locus on chromosome 1q44 (D1S1609) demonstrated a significant increase (P=0.025) in LOD score from 0.15 to 3.01 with a broad definition of the schizophrenia phenotype and a dominant mode of inheritance. This result replicates a previously reported positive result of linkage of schizophrenia spectrum disorders to this area of the genome. We also illustrated that simulation studies are pivotal in evaluating the significance of results obtained with newer statistical methods, when multiple, but not independent, tests are performed, and when sample stratification is utilized to reduce the impact of heterogeneity or assess the interaction between loci.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15340354      PMCID: PMC3133762          DOI: 10.1038/sj.mp.4001582

Source DB:  PubMed          Journal:  Mol Psychiatry        ISSN: 1359-4184            Impact factor:   15.992


  75 in total

1.  Detection and integration of genotyping errors in statistical genetics.

Authors:  Eric Sobel; Jeanette C Papp; Kenneth Lange
Journal:  Am J Hum Genet       Date:  2002-01-08       Impact factor: 11.025

2.  Undetected genotyping errors cause apparent overtransmission of common alleles in the transmission/disequilibrium test.

Authors:  Adele A Mitchell; David J Cutler; Aravinda Chakravarti
Journal:  Am J Hum Genet       Date:  2003-02-13       Impact factor: 11.025

3.  Tumour necrosis factor alpha (-238 and -308) and beta gene polymorphisms in pulmonary tuberculosis: haplotype analysis with HLA-A, B and DR genes.

Authors:  P Selvaraj; U Sriram; S Mathan Kurian; A M Reetha; P R Narayanan
Journal:  Tuberculosis (Edinb)       Date:  2001       Impact factor: 3.131

4.  Control of synaptic strength by glial TNFalpha.

Authors:  Eric C Beattie; David Stellwagen; Wade Morishita; Jacqueline C Bresnahan; Byeong Keun Ha; Mark Von Zastrow; Michael S Beattie; Robert C Malenka
Journal:  Science       Date:  2002-03-22       Impact factor: 47.728

5.  Modest evidence for linkage and possible confirmation of association between NOTCH4 and schizophrenia in a large Veterans Affairs Cooperative Study sample.

Authors:  A D Skol; K A Young; D W Tsuang; S V Faraone; S L Haverstock; S Bingham; S Prabhudesai; F Mena; A S Menon; Chang-En Yu; Paul Rundell; J Pepple; F Sauter; C Baldwin; D Weiss; J Collins; T Keith; M Boehnke; G D Schellenberg; M T Tsuang
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2003-04-01       Impact factor: 3.568

6.  Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia.

Authors:  Norbert Müller; Michael Riedel; Constanze Scheppach; Bernd Brandstätter; Safet Sokullu; Karin Krampe; Markus Ulmschneider; Rolf R Engel; Hans-Jürgen Möller; Markus J Schwarz
Journal:  Am J Psychiatry       Date:  2002-06       Impact factor: 18.112

Review 7.  Schizophrenia and genetics: new insights.

Authors:  Anne S Bassett; Eva W Chow; Rosanna Weksberg; Linda Brzustowicz
Journal:  Curr Psychiatry Rep       Date:  2002-08       Impact factor: 5.285

8.  Interleukin-1beta promotes oligodendrocyte death through glutamate excitotoxicity.

Authors:  Jennifer L Takahashi; Fabrizio Giuliani; Christopher Power; Yoshinori Imai; V Wee Yong
Journal:  Ann Neurol       Date:  2003-05       Impact factor: 10.422

Review 9.  Genes for schizophrenia? Recent findings and their pathophysiological implications.

Authors:  Paul J Harrison; Michael J Owen
Journal:  Lancet       Date:  2003-02-01       Impact factor: 79.321

Review 10.  Schizophrenia: neural mechanisms for novel therapies.

Authors:  Akira Sawa; Solomon H Snyder
Journal:  Mol Med       Date:  2003 Jan-Feb       Impact factor: 6.354

View more
  8 in total

1.  Decreased serum TNF-alpha levels in chronic schizophrenia patients on long-term antipsychotics: correlation with psychopathology and cognition.

Authors:  Meng Han Lv; Yun Long Tan; Shao Xiao Yan; Li Tian; Da Chun Chen; Shu Ping Tan; Zhi Ren Wang; Fu De Yang; Jin H Yoon; Giovana B Zunta-Soares; Jair C Soares; Xiang Yang Zhang
Journal:  Psychopharmacology (Berl)       Date:  2014-06-24       Impact factor: 4.530

2.  Association of synapsin 2 with schizophrenia in families of Northern European ancestry.

Authors:  Viatcheslav Saviouk; Michael P Moreau; Irina V Tereshchenko; Linda M Brzustowicz
Journal:  Schizophr Res       Date:  2007-09-04       Impact factor: 4.939

3.  The nuclear factor-κB inhibitor pyrrolidine dithiocarbamate reduces polyinosinic-polycytidilic acid-induced immune response in pregnant rats and the behavioral defects of their adult offspring.

Authors:  Xueqin Song; Wenqiang Li; Yongfeng Yang; Jingping Zhao; Chengdi Jiang; Wei Li; Luxian Lv
Journal:  Behav Brain Funct       Date:  2011-12-31       Impact factor: 3.759

4.  Pro-inflammatory cytokines and their epistatic interactions in genetic susceptibility to schizophrenia.

Authors:  Lekshmy Srinivas; Neetha N Vellichirammal; Ann Mary Alex; Chandrasekharan Nair; Indu V Nair; Moinak Banerjee
Journal:  J Neuroinflammation       Date:  2016-05-13       Impact factor: 8.322

5.  Investigating the Causal Relationship of C-Reactive Protein with 32 Complex Somatic and Psychiatric Outcomes: A Large-Scale Cross-Consortium Mendelian Randomization Study.

Authors:  Bram P Prins; Ali Abbasi; Anson Wong; Ahmad Vaez; Ilja Nolte; Nora Franceschini; Philip E Stuart; Javier Guterriez Achury; Vanisha Mistry; Jonathan P Bradfield; Ana M Valdes; Jose Bras; Aleksey Shatunov; Chen Lu; Buhm Han; Soumya Raychaudhuri; Steve Bevan; Maureen D Mayes; Lam C Tsoi; Evangelos Evangelou; Rajan P Nair; Struan F A Grant; Constantin Polychronakos; Timothy R D Radstake; David A van Heel; Melanie L Dunstan; Nicholas W Wood; Ammar Al-Chalabi; Abbas Dehghan; Hakon Hakonarson; Hugh S Markus; James T Elder; Jo Knight; Dan E Arking; Timothy D Spector; Bobby P C Koeleman; Cornelia M van Duijn; Javier Martin; Andrew P Morris; Rinse K Weersma; Cisca Wijmenga; Patricia B Munroe; John R B Perry; Jennie G Pouget; Yalda Jamshidi; Harold Snieder; Behrooz Z Alizadeh
Journal:  PLoS Med       Date:  2016-06-21       Impact factor: 11.069

6.  C-Reactive Protein as a Peripheral Biomarker in Schizophrenia. An Updated Systematic Review.

Authors:  Guillaume Fond; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Front Psychiatry       Date:  2018-08-23       Impact factor: 4.157

7.  An association study of ADSS gene polymorphisms with schizophrenia.

Authors:  Fuquan Zhang; Pak C Sham; Hua Fan; Yong Xu; Xuezhu Huang; Honcheong So; Yuqing Song; Pozi Liu
Journal:  Behav Brain Funct       Date:  2008-08-24       Impact factor: 3.759

8.  NLRP3 Influences Cognitive Function in Schizophrenia in Han Chinese.

Authors:  Ruimei Liu; Wei Tang; Weiping Wang; Feikang Xu; Weixing Fan; Yi Zhang; Chen Zhang
Journal:  Front Genet       Date:  2021-12-10       Impact factor: 4.599

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.